AICDA and leukemia: APOBEC3 signatures are prevalent in leukaemias (Rebhandl et al., 2014), while AID was demonstrated to induce hypermutation and chromosomal translocation in B cell lymphomas (Robbiani and Nussenzweig, 2013).